NO
My post was based on the announcement about Trophon 2. You will recall that NAN got FDA approval much quicker than planned for and resulted in marketing difficulties. I was thinking that FDA etc would be quick to rush NAN's product through into the healthcare sector and upset NAN's plans.
WOW NAN, page-4
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
-0.010(0.36%) |
Mkt cap ! $833.1M | |||
| Open | High | Low | Value | Volume |
| $2.73 | $2.76 | $2.71 | $1.479M | 541.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2044 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.76 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.76 |
Change
-0.010 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $2.72 | $2.76 | $2.71 | 172952 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| NAN (ASX) Chart |